The roles of calponin and caldesmon and their interaction in regulation of smooth muscle contraction are controversial. Recently, strong binding between these two proteins has been reported (Graceffa, P., Adam, L. P., and Morgan, K. G. (1996) J. Biol. Chem. 271, 30336 -30339). Results in this paper fail to confirm their data and are consistent with the concept of independent functions for calponin and caldesmon.To examine the ability of duck gizzard caldesmon to interact with calponin, three caldesmon derivatives, each containing a different sulfhydryl-specific reporter probe (6-acryloyl-2-dimethylaminonaphtalene, N-(1-pyrenyl)iodoacetamide, and N-iodoacetyl-N-(5-sulfo-1-naphtylo)ethylenediamine) attached to a single cysteine located in the C-terminal domain, were synthesized. Addition of calponin to labeled caldesmon at both low and physiological salt concentrations did not induce any changes in fluorescence intensity or maximum shift. Under the same conditions, calmodulin and tropomyosin (known to bind to the C terminus of caldesmon) produced substantial changes in these spectral parameters. Gel filtration of an equimolar caldesmon-calponin mixture on a fast protein liquid chromatography Superose-12 column revealed two base-line-separated peaks, the first containing only caldesmon and the second only calponin, thus confirming the lack of any interaction between these two proteins. Also, the addition of calponin did not change the fluorescence parameters of labeled caldesmon in complexes with F-actin and F-actin-tropomyosin.The primary mechanism for smooth muscle regulation, necessary to initiate contraction, involves phosphorylation of the 20-kDa myosin light chains by a specific Ca 2ϩ /calmodulin-dependent myosin light chain kinase (for reviews see Refs. 1-3). It is postulated that the specific thin filament-associated proteins caldesmon and calponin take part in the secondary mechanism of regulation, probably during the relaxation phase. This view is supported by in vitro experiments showing that both of these proteins inhibit actin-activated ATPase activity of myosin, mobility of actin filaments over immobilized myosin in motility assay, and skinned muscle contraction. This inhibition can be reversed by Ca 2ϩ /calmodulin, or other Ca 2ϩ -binding proteins (like S100 or caltropin), and by phosphorylation with protein kinase C or casein kinase II (Refs. 3-6 and references therein).Studies by Makuch et al. (7) revealed that calponin and caldesmon compete for the binding sites on actin filament, calponin being more effective at displacing caldesmon than vice versa. Similar results were obtained in the Chalovich laboratory (8). This suggested that calponin and caldesmon do not form a mutual complex on actin and reside on different populations of thin filaments in vivo. Immunofluorescence and immunogold electron microscopy confirmed this suggestion showing that, whereas caldesmon is present exclusively in the contractile domain, calponin is primarily, although not exclusively, located in the cytoskeletal domain of...